nodes	percent_of_prediction	percent_of_DWPC	metapath
Goserelin—breast cancer—colon cancer	0.893	1	CtDrD
Goserelin—Leukopenia—Fluorouracil—colon cancer	0.000185	0.00173	CcSEcCtD
Goserelin—Depression—Capecitabine—colon cancer	0.000184	0.00172	CcSEcCtD
Goserelin—Acute coronary syndrome—Capecitabine—colon cancer	0.000182	0.0017	CcSEcCtD
Goserelin—Cerebrovascular accident—Methotrexate—colon cancer	0.000182	0.0017	CcSEcCtD
Goserelin—Lethargy—Methotrexate—colon cancer	0.000182	0.0017	CcSEcCtD
Goserelin—Renal failure—Capecitabine—colon cancer	0.000182	0.00169	CcSEcCtD
Goserelin—Discomfort—Irinotecan—colon cancer	0.000182	0.00169	CcSEcCtD
Goserelin—Myocardial infarction—Capecitabine—colon cancer	0.000181	0.00169	CcSEcCtD
Goserelin—Oedema—Vincristine—colon cancer	0.000181	0.00169	CcSEcCtD
Goserelin—Anaphylactic shock—Vincristine—colon cancer	0.000181	0.00169	CcSEcCtD
Goserelin—Jaundice—Capecitabine—colon cancer	0.00018	0.00168	CcSEcCtD
Goserelin—Infection—Vincristine—colon cancer	0.00018	0.00168	CcSEcCtD
Goserelin—Urinary tract infection—Capecitabine—colon cancer	0.00018	0.00168	CcSEcCtD
Goserelin—Convulsion—Fluorouracil—colon cancer	0.000179	0.00167	CcSEcCtD
Goserelin—Osteoarthritis—Methotrexate—colon cancer	0.000179	0.00167	CcSEcCtD
Goserelin—Confusional state—Irinotecan—colon cancer	0.000178	0.00166	CcSEcCtD
Goserelin—Nervous system disorder—Vincristine—colon cancer	0.000177	0.00165	CcSEcCtD
Goserelin—Thrombocytopenia—Vincristine—colon cancer	0.000177	0.00165	CcSEcCtD
Goserelin—Haematuria—Capecitabine—colon cancer	0.000176	0.00164	CcSEcCtD
Goserelin—Oedema—Irinotecan—colon cancer	0.000176	0.00164	CcSEcCtD
Goserelin—Anaphylactic shock—Irinotecan—colon cancer	0.000176	0.00164	CcSEcCtD
Goserelin—Myalgia—Fluorouracil—colon cancer	0.000176	0.00164	CcSEcCtD
Goserelin—Chest pain—Fluorouracil—colon cancer	0.000176	0.00164	CcSEcCtD
Goserelin—Infection—Irinotecan—colon cancer	0.000175	0.00163	CcSEcCtD
Goserelin—Hyperhidrosis—Vincristine—colon cancer	0.000175	0.00163	CcSEcCtD
Goserelin—Epistaxis—Capecitabine—colon cancer	0.000174	0.00163	CcSEcCtD
Goserelin—Discomfort—Fluorouracil—colon cancer	0.000174	0.00162	CcSEcCtD
Goserelin—Shock—Irinotecan—colon cancer	0.000173	0.00162	CcSEcCtD
Goserelin—Nervous system disorder—Irinotecan—colon cancer	0.000173	0.00161	CcSEcCtD
Goserelin—Thrombocytopenia—Irinotecan—colon cancer	0.000173	0.00161	CcSEcCtD
Goserelin—Anorexia—Vincristine—colon cancer	0.000172	0.00161	CcSEcCtD
Goserelin—Hyperhidrosis—Irinotecan—colon cancer	0.00017	0.00159	CcSEcCtD
Goserelin—Confusional state—Fluorouracil—colon cancer	0.00017	0.00159	CcSEcCtD
Goserelin—Mood swings—Methotrexate—colon cancer	0.000169	0.00158	CcSEcCtD
Goserelin—Hypotension—Vincristine—colon cancer	0.000169	0.00158	CcSEcCtD
Goserelin—Anaphylactic shock—Fluorouracil—colon cancer	0.000169	0.00157	CcSEcCtD
Goserelin—Oedema—Fluorouracil—colon cancer	0.000169	0.00157	CcSEcCtD
Goserelin—Anorexia—Irinotecan—colon cancer	0.000168	0.00157	CcSEcCtD
Goserelin—Infection—Fluorouracil—colon cancer	0.000168	0.00156	CcSEcCtD
Goserelin—Haemoglobin—Capecitabine—colon cancer	0.000167	0.00156	CcSEcCtD
Goserelin—Rhinitis—Capecitabine—colon cancer	0.000166	0.00155	CcSEcCtD
Goserelin—Hepatitis—Capecitabine—colon cancer	0.000166	0.00155	CcSEcCtD
Goserelin—Haemorrhage—Capecitabine—colon cancer	0.000166	0.00155	CcSEcCtD
Goserelin—Nervous system disorder—Fluorouracil—colon cancer	0.000166	0.00154	CcSEcCtD
Goserelin—Thrombocytopenia—Fluorouracil—colon cancer	0.000165	0.00154	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Vincristine—colon cancer	0.000165	0.00154	CcSEcCtD
Goserelin—Pharyngitis—Capecitabine—colon cancer	0.000165	0.00154	CcSEcCtD
Goserelin—Tachycardia—Fluorouracil—colon cancer	0.000165	0.00154	CcSEcCtD
Goserelin—Hypotension—Irinotecan—colon cancer	0.000165	0.00153	CcSEcCtD
Goserelin—Urinary tract disorder—Capecitabine—colon cancer	0.000164	0.00153	CcSEcCtD
Goserelin—Insomnia—Vincristine—colon cancer	0.000164	0.00153	CcSEcCtD
Goserelin—Oedema peripheral—Capecitabine—colon cancer	0.000164	0.00152	CcSEcCtD
Goserelin—Urethral disorder—Capecitabine—colon cancer	0.000163	0.00152	CcSEcCtD
Goserelin—Paraesthesia—Vincristine—colon cancer	0.000162	0.00151	CcSEcCtD
Goserelin—Breast disorder—Methotrexate—colon cancer	0.000161	0.0015	CcSEcCtD
Goserelin—Anorexia—Fluorouracil—colon cancer	0.000161	0.0015	CcSEcCtD
Goserelin—Insomnia—Irinotecan—colon cancer	0.000159	0.00149	CcSEcCtD
Goserelin—Paraesthesia—Irinotecan—colon cancer	0.000158	0.00147	CcSEcCtD
Goserelin—Hypotension—Fluorouracil—colon cancer	0.000158	0.00147	CcSEcCtD
Goserelin—Decreased appetite—Vincristine—colon cancer	0.000157	0.00147	CcSEcCtD
Goserelin—Dyspnoea—Irinotecan—colon cancer	0.000157	0.00146	CcSEcCtD
Goserelin—Somnolence—Irinotecan—colon cancer	0.000157	0.00146	CcSEcCtD
Goserelin—Fatigue—Vincristine—colon cancer	0.000156	0.00145	CcSEcCtD
Goserelin—Eye disorder—Capecitabine—colon cancer	0.000155	0.00145	CcSEcCtD
Goserelin—Dyspepsia—Irinotecan—colon cancer	0.000155	0.00145	CcSEcCtD
Goserelin—Pain—Vincristine—colon cancer	0.000155	0.00144	CcSEcCtD
Goserelin—Constipation—Vincristine—colon cancer	0.000155	0.00144	CcSEcCtD
Goserelin—Cardiac disorder—Capecitabine—colon cancer	0.000154	0.00144	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000154	0.00143	CcSEcCtD
Goserelin—Decreased appetite—Irinotecan—colon cancer	0.000153	0.00143	CcSEcCtD
Goserelin—Insomnia—Fluorouracil—colon cancer	0.000153	0.00142	CcSEcCtD
Goserelin—Fatigue—Irinotecan—colon cancer	0.000152	0.00142	CcSEcCtD
Goserelin—Paraesthesia—Fluorouracil—colon cancer	0.000152	0.00141	CcSEcCtD
Goserelin—Constipation—Irinotecan—colon cancer	0.000151	0.0014	CcSEcCtD
Goserelin—Pain—Irinotecan—colon cancer	0.000151	0.0014	CcSEcCtD
Goserelin—Angiopathy—Capecitabine—colon cancer	0.000151	0.0014	CcSEcCtD
Goserelin—Dyspnoea—Fluorouracil—colon cancer	0.00015	0.0014	CcSEcCtD
Goserelin—Somnolence—Fluorouracil—colon cancer	0.00015	0.0014	CcSEcCtD
Goserelin—Immune system disorder—Capecitabine—colon cancer	0.00015	0.0014	CcSEcCtD
Goserelin—Chills—Capecitabine—colon cancer	0.000149	0.00139	CcSEcCtD
Goserelin—Dyspepsia—Fluorouracil—colon cancer	0.000149	0.00138	CcSEcCtD
Goserelin—Arrhythmia—Capecitabine—colon cancer	0.000148	0.00138	CcSEcCtD
Goserelin—Gastrointestinal pain—Vincristine—colon cancer	0.000148	0.00138	CcSEcCtD
Goserelin—Decreased appetite—Fluorouracil—colon cancer	0.000147	0.00137	CcSEcCtD
Goserelin—Alopecia—Capecitabine—colon cancer	0.000147	0.00137	CcSEcCtD
Goserelin—Mental disorder—Capecitabine—colon cancer	0.000145	0.00136	CcSEcCtD
Goserelin—Feeling abnormal—Irinotecan—colon cancer	0.000145	0.00135	CcSEcCtD
Goserelin—Erythema—Capecitabine—colon cancer	0.000145	0.00135	CcSEcCtD
Goserelin—Malnutrition—Capecitabine—colon cancer	0.000145	0.00135	CcSEcCtD
Goserelin—Dysuria—Methotrexate—colon cancer	0.000144	0.00135	CcSEcCtD
Goserelin—Pain—Fluorouracil—colon cancer	0.000144	0.00135	CcSEcCtD
Goserelin—Gastrointestinal pain—Irinotecan—colon cancer	0.000144	0.00134	CcSEcCtD
Goserelin—Upper respiratory tract infection—Methotrexate—colon cancer	0.000143	0.00134	CcSEcCtD
Goserelin—Abdominal pain—Vincristine—colon cancer	0.000143	0.00133	CcSEcCtD
Goserelin—Body temperature increased—Vincristine—colon cancer	0.000143	0.00133	CcSEcCtD
Goserelin—Flatulence—Capecitabine—colon cancer	0.000142	0.00133	CcSEcCtD
Goserelin—Erectile dysfunction—Methotrexate—colon cancer	0.000142	0.00133	CcSEcCtD
Goserelin—Photosensitivity reaction—Methotrexate—colon cancer	0.000141	0.00131	CcSEcCtD
Goserelin—Back pain—Capecitabine—colon cancer	0.00014	0.0013	CcSEcCtD
Goserelin—Abdominal pain—Irinotecan—colon cancer	0.000139	0.0013	CcSEcCtD
Goserelin—Body temperature increased—Irinotecan—colon cancer	0.000139	0.0013	CcSEcCtD
Goserelin—Feeling abnormal—Fluorouracil—colon cancer	0.000139	0.0013	CcSEcCtD
Goserelin—Muscle spasms—Capecitabine—colon cancer	0.000139	0.00129	CcSEcCtD
Goserelin—Pneumonia—Methotrexate—colon cancer	0.000138	0.00129	CcSEcCtD
Goserelin—Drowsiness—Methotrexate—colon cancer	0.000138	0.00128	CcSEcCtD
Goserelin—Depression—Methotrexate—colon cancer	0.000137	0.00128	CcSEcCtD
Goserelin—Vision blurred—Capecitabine—colon cancer	0.000136	0.00127	CcSEcCtD
Goserelin—Renal failure—Methotrexate—colon cancer	0.000135	0.00126	CcSEcCtD
Goserelin—Ill-defined disorder—Capecitabine—colon cancer	0.000134	0.00125	CcSEcCtD
Goserelin—Urticaria—Fluorouracil—colon cancer	0.000134	0.00125	CcSEcCtD
Goserelin—Anaemia—Capecitabine—colon cancer	0.000134	0.00124	CcSEcCtD
Goserelin—Body temperature increased—Fluorouracil—colon cancer	0.000133	0.00124	CcSEcCtD
Goserelin—Hypersensitivity—Vincristine—colon cancer	0.000133	0.00124	CcSEcCtD
Goserelin—Sweating—Methotrexate—colon cancer	0.000132	0.00123	CcSEcCtD
Goserelin—Haematuria—Methotrexate—colon cancer	0.000131	0.00122	CcSEcCtD
Goserelin—Malaise—Capecitabine—colon cancer	0.00013	0.00121	CcSEcCtD
Goserelin—Epistaxis—Methotrexate—colon cancer	0.00013	0.00121	CcSEcCtD
Goserelin—Hypersensitivity—Irinotecan—colon cancer	0.00013	0.00121	CcSEcCtD
Goserelin—Asthenia—Vincristine—colon cancer	0.00013	0.00121	CcSEcCtD
Goserelin—Leukopenia—Capecitabine—colon cancer	0.000129	0.00121	CcSEcCtD
Goserelin—Palpitations—Capecitabine—colon cancer	0.000128	0.00119	CcSEcCtD
Goserelin—Asthenia—Irinotecan—colon cancer	0.000126	0.00118	CcSEcCtD
Goserelin—Cough—Capecitabine—colon cancer	0.000126	0.00118	CcSEcCtD
Goserelin—Hypertension—Capecitabine—colon cancer	0.000125	0.00116	CcSEcCtD
Goserelin—Hypersensitivity—Fluorouracil—colon cancer	0.000124	0.00116	CcSEcCtD
Goserelin—Haemoglobin—Methotrexate—colon cancer	0.000124	0.00116	CcSEcCtD
Goserelin—Diarrhoea—Vincristine—colon cancer	0.000124	0.00115	CcSEcCtD
Goserelin—Haemorrhage—Methotrexate—colon cancer	0.000124	0.00115	CcSEcCtD
Goserelin—Hepatitis—Methotrexate—colon cancer	0.000124	0.00115	CcSEcCtD
Goserelin—Arthralgia—Capecitabine—colon cancer	0.000123	0.00115	CcSEcCtD
Goserelin—Chest pain—Capecitabine—colon cancer	0.000123	0.00115	CcSEcCtD
Goserelin—Myalgia—Capecitabine—colon cancer	0.000123	0.00115	CcSEcCtD
Goserelin—Pharyngitis—Methotrexate—colon cancer	0.000123	0.00114	CcSEcCtD
Goserelin—Anxiety—Capecitabine—colon cancer	0.000123	0.00114	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000122	0.00114	CcSEcCtD
Goserelin—Urinary tract disorder—Methotrexate—colon cancer	0.000122	0.00114	CcSEcCtD
Goserelin—Discomfort—Capecitabine—colon cancer	0.000122	0.00113	CcSEcCtD
Goserelin—Urethral disorder—Methotrexate—colon cancer	0.000121	0.00113	CcSEcCtD
Goserelin—Diarrhoea—Irinotecan—colon cancer	0.000121	0.00112	CcSEcCtD
Goserelin—Dry mouth—Capecitabine—colon cancer	0.00012	0.00112	CcSEcCtD
Goserelin—Dizziness—Vincristine—colon cancer	0.00012	0.00112	CcSEcCtD
Goserelin—Pruritus—Fluorouracil—colon cancer	0.000119	0.00111	CcSEcCtD
Goserelin—Confusional state—Capecitabine—colon cancer	0.000119	0.00111	CcSEcCtD
Goserelin—Oedema—Capecitabine—colon cancer	0.000118	0.0011	CcSEcCtD
Goserelin—Infection—Capecitabine—colon cancer	0.000117	0.00109	CcSEcCtD
Goserelin—Dizziness—Irinotecan—colon cancer	0.000117	0.00109	CcSEcCtD
Goserelin—Shock—Capecitabine—colon cancer	0.000116	0.00108	CcSEcCtD
Goserelin—Nervous system disorder—Capecitabine—colon cancer	0.000116	0.00108	CcSEcCtD
Goserelin—Eye disorder—Methotrexate—colon cancer	0.000115	0.00108	CcSEcCtD
Goserelin—Diarrhoea—Fluorouracil—colon cancer	0.000115	0.00108	CcSEcCtD
Goserelin—Thrombocytopenia—Capecitabine—colon cancer	0.000115	0.00108	CcSEcCtD
Goserelin—Tachycardia—Capecitabine—colon cancer	0.000115	0.00107	CcSEcCtD
Goserelin—Vomiting—Vincristine—colon cancer	0.000115	0.00107	CcSEcCtD
Goserelin—Cardiac disorder—Methotrexate—colon cancer	0.000115	0.00107	CcSEcCtD
Goserelin—Skin disorder—Capecitabine—colon cancer	0.000115	0.00107	CcSEcCtD
Goserelin—Rash—Vincristine—colon cancer	0.000114	0.00106	CcSEcCtD
Goserelin—Hyperhidrosis—Capecitabine—colon cancer	0.000114	0.00106	CcSEcCtD
Goserelin—Dermatitis—Vincristine—colon cancer	0.000114	0.00106	CcSEcCtD
Goserelin—Headache—Vincristine—colon cancer	0.000113	0.00106	CcSEcCtD
Goserelin—Anorexia—Capecitabine—colon cancer	0.000112	0.00105	CcSEcCtD
Goserelin—Angiopathy—Methotrexate—colon cancer	0.000112	0.00105	CcSEcCtD
Goserelin—Vomiting—Irinotecan—colon cancer	0.000112	0.00104	CcSEcCtD
Goserelin—Immune system disorder—Methotrexate—colon cancer	0.000112	0.00104	CcSEcCtD
Goserelin—Dizziness—Fluorouracil—colon cancer	0.000112	0.00104	CcSEcCtD
Goserelin—Rash—Irinotecan—colon cancer	0.000111	0.00104	CcSEcCtD
Goserelin—Dermatitis—Irinotecan—colon cancer	0.000111	0.00103	CcSEcCtD
Goserelin—Chills—Methotrexate—colon cancer	0.000111	0.00103	CcSEcCtD
Goserelin—Headache—Irinotecan—colon cancer	0.00011	0.00103	CcSEcCtD
Goserelin—Hypotension—Capecitabine—colon cancer	0.00011	0.00103	CcSEcCtD
Goserelin—Alopecia—Methotrexate—colon cancer	0.000109	0.00102	CcSEcCtD
Goserelin—Mental disorder—Methotrexate—colon cancer	0.000108	0.00101	CcSEcCtD
Goserelin—Erythema—Methotrexate—colon cancer	0.000108	0.001	CcSEcCtD
Goserelin—Malnutrition—Methotrexate—colon cancer	0.000108	0.001	CcSEcCtD
Goserelin—Nausea—Vincristine—colon cancer	0.000107	0.001	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000107	0.001	CcSEcCtD
Goserelin—Vomiting—Fluorouracil—colon cancer	0.000107	0.001	CcSEcCtD
Goserelin—Insomnia—Capecitabine—colon cancer	0.000107	0.000994	CcSEcCtD
Goserelin—Rash—Fluorouracil—colon cancer	0.000106	0.000992	CcSEcCtD
Goserelin—Dermatitis—Fluorouracil—colon cancer	0.000106	0.000991	CcSEcCtD
Goserelin—Paraesthesia—Capecitabine—colon cancer	0.000106	0.000987	CcSEcCtD
Goserelin—Headache—Fluorouracil—colon cancer	0.000106	0.000985	CcSEcCtD
Goserelin—Dyspnoea—Capecitabine—colon cancer	0.000105	0.00098	CcSEcCtD
Goserelin—Nausea—Irinotecan—colon cancer	0.000105	0.000976	CcSEcCtD
Goserelin—Back pain—Methotrexate—colon cancer	0.000104	0.00097	CcSEcCtD
Goserelin—Dyspepsia—Capecitabine—colon cancer	0.000104	0.000968	CcSEcCtD
Goserelin—Decreased appetite—Capecitabine—colon cancer	0.000103	0.000956	CcSEcCtD
Goserelin—Fatigue—Capecitabine—colon cancer	0.000102	0.000948	CcSEcCtD
Goserelin—Vision blurred—Methotrexate—colon cancer	0.000101	0.000945	CcSEcCtD
Goserelin—Pain—Capecitabine—colon cancer	0.000101	0.00094	CcSEcCtD
Goserelin—Constipation—Capecitabine—colon cancer	0.000101	0.00094	CcSEcCtD
Goserelin—Nausea—Fluorouracil—colon cancer	0.0001	0.000934	CcSEcCtD
Goserelin—Ill-defined disorder—Methotrexate—colon cancer	9.98e-05	0.00093	CcSEcCtD
Goserelin—Anaemia—Methotrexate—colon cancer	9.94e-05	0.000927	CcSEcCtD
Goserelin—Feeling abnormal—Capecitabine—colon cancer	9.72e-05	0.000906	CcSEcCtD
Goserelin—Malaise—Methotrexate—colon cancer	9.7e-05	0.000904	CcSEcCtD
Goserelin—Gastrointestinal pain—Capecitabine—colon cancer	9.64e-05	0.000899	CcSEcCtD
Goserelin—Leukopenia—Methotrexate—colon cancer	9.63e-05	0.000898	CcSEcCtD
Goserelin—Cough—Methotrexate—colon cancer	9.39e-05	0.000875	CcSEcCtD
Goserelin—Urticaria—Capecitabine—colon cancer	9.37e-05	0.000873	CcSEcCtD
Goserelin—Abdominal pain—Capecitabine—colon cancer	9.32e-05	0.000869	CcSEcCtD
Goserelin—Body temperature increased—Capecitabine—colon cancer	9.32e-05	0.000869	CcSEcCtD
Goserelin—Convulsion—Methotrexate—colon cancer	9.32e-05	0.000869	CcSEcCtD
Goserelin—Arthralgia—Methotrexate—colon cancer	9.16e-05	0.000854	CcSEcCtD
Goserelin—Myalgia—Methotrexate—colon cancer	9.16e-05	0.000854	CcSEcCtD
Goserelin—Chest pain—Methotrexate—colon cancer	9.16e-05	0.000854	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	9.1e-05	0.000848	CcSEcCtD
Goserelin—Discomfort—Methotrexate—colon cancer	9.05e-05	0.000843	CcSEcCtD
Goserelin—Confusional state—Methotrexate—colon cancer	8.85e-05	0.000825	CcSEcCtD
Goserelin—Anaphylactic shock—Methotrexate—colon cancer	8.78e-05	0.000818	CcSEcCtD
Goserelin—Infection—Methotrexate—colon cancer	8.72e-05	0.000813	CcSEcCtD
Goserelin—Hypersensitivity—Capecitabine—colon cancer	8.69e-05	0.00081	CcSEcCtD
Goserelin—Nervous system disorder—Methotrexate—colon cancer	8.61e-05	0.000803	CcSEcCtD
Goserelin—Thrombocytopenia—Methotrexate—colon cancer	8.6e-05	0.000801	CcSEcCtD
Goserelin—Skin disorder—Methotrexate—colon cancer	8.53e-05	0.000795	CcSEcCtD
Goserelin—Hyperhidrosis—Methotrexate—colon cancer	8.49e-05	0.000791	CcSEcCtD
Goserelin—Asthenia—Capecitabine—colon cancer	8.46e-05	0.000789	CcSEcCtD
Goserelin—Anorexia—Methotrexate—colon cancer	8.37e-05	0.00078	CcSEcCtD
Goserelin—Pruritus—Capecitabine—colon cancer	8.34e-05	0.000778	CcSEcCtD
Goserelin—Hypotension—Methotrexate—colon cancer	8.2e-05	0.000765	CcSEcCtD
Goserelin—Diarrhoea—Capecitabine—colon cancer	8.07e-05	0.000752	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Methotrexate—colon cancer	8e-05	0.000746	CcSEcCtD
Goserelin—Insomnia—Methotrexate—colon cancer	7.94e-05	0.00074	CcSEcCtD
Goserelin—Paraesthesia—Methotrexate—colon cancer	7.88e-05	0.000735	CcSEcCtD
Goserelin—Dyspnoea—Methotrexate—colon cancer	7.83e-05	0.00073	CcSEcCtD
Goserelin—Somnolence—Methotrexate—colon cancer	7.81e-05	0.000728	CcSEcCtD
Goserelin—Dizziness—Capecitabine—colon cancer	7.8e-05	0.000727	CcSEcCtD
Goserelin—Dyspepsia—Methotrexate—colon cancer	7.73e-05	0.00072	CcSEcCtD
Goserelin—Decreased appetite—Methotrexate—colon cancer	7.63e-05	0.000711	CcSEcCtD
Goserelin—Fatigue—Methotrexate—colon cancer	7.57e-05	0.000706	CcSEcCtD
Goserelin—Pain—Methotrexate—colon cancer	7.51e-05	0.0007	CcSEcCtD
Goserelin—Vomiting—Capecitabine—colon cancer	7.5e-05	0.000699	CcSEcCtD
Goserelin—Rash—Capecitabine—colon cancer	7.44e-05	0.000693	CcSEcCtD
Goserelin—Dermatitis—Capecitabine—colon cancer	7.43e-05	0.000692	CcSEcCtD
Goserelin—Headache—Capecitabine—colon cancer	7.39e-05	0.000689	CcSEcCtD
Goserelin—Feeling abnormal—Methotrexate—colon cancer	7.24e-05	0.000674	CcSEcCtD
Goserelin—Gastrointestinal pain—Methotrexate—colon cancer	7.18e-05	0.000669	CcSEcCtD
Goserelin—Nausea—Capecitabine—colon cancer	7.01e-05	0.000653	CcSEcCtD
Goserelin—Urticaria—Methotrexate—colon cancer	6.97e-05	0.00065	CcSEcCtD
Goserelin—Abdominal pain—Methotrexate—colon cancer	6.94e-05	0.000647	CcSEcCtD
Goserelin—Body temperature increased—Methotrexate—colon cancer	6.94e-05	0.000647	CcSEcCtD
Goserelin—Hypersensitivity—Methotrexate—colon cancer	6.47e-05	0.000603	CcSEcCtD
Goserelin—Asthenia—Methotrexate—colon cancer	6.3e-05	0.000587	CcSEcCtD
Goserelin—Pruritus—Methotrexate—colon cancer	6.21e-05	0.000579	CcSEcCtD
Goserelin—Diarrhoea—Methotrexate—colon cancer	6.01e-05	0.00056	CcSEcCtD
Goserelin—Dizziness—Methotrexate—colon cancer	5.81e-05	0.000541	CcSEcCtD
Goserelin—Vomiting—Methotrexate—colon cancer	5.58e-05	0.00052	CcSEcCtD
Goserelin—Rash—Methotrexate—colon cancer	5.54e-05	0.000516	CcSEcCtD
Goserelin—Dermatitis—Methotrexate—colon cancer	5.53e-05	0.000515	CcSEcCtD
Goserelin—Headache—Methotrexate—colon cancer	5.5e-05	0.000513	CcSEcCtD
Goserelin—Nausea—Methotrexate—colon cancer	5.22e-05	0.000486	CcSEcCtD
